6101 - 6150 of 8620 Results
Title
Year
-
OPENTitle: Subcortical Intermittent Theta-Burst Stimulation (iTBS) Increases Theta-Power in Dorsolateral Prefrontal Cortex (DLPFC)Journal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00041Best OA location URL: https://doi.org/10.3389/fnins.2020.00041Citation Count: 28
-
OPENTitle: Accelerating Medicines Partnership: Parkinson's Disease. Genetic ResourceJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1795End Page: 1804Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28549Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28549Citation Count: 98
-
RESTRICTEDTitle: Attitudes toward use and timing of deep brain stimulation: a patient’s with DBS perspectiveJournal Name: Clinical Neurology and NeurosurgeryPublisher: Elsevier BVVol: 203Issue #:Start Page: 106553End Page: 106553Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clineuro.2021.106553Citation Count: 6
-
RESTRICTEDTitle: A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeysJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 39Issue #: 3Start Page: 352End Page: 361Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2010.05.001Best OA location URL: https://zenodo.org/record/3420959Citation Count: 150
-
OPENTitle: Movement disorders in non-encephalopathic Hashimoto's thyroiditisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 55Issue #:Start Page: 141End Page: 142Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.06.008Best OA location URL: https://zenodo.org/record/3873759Citation Count: 17
-
OPENTitle: Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2945End Page: 2950Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28779Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8688198Citation Count: 135
-
RESTRICTEDTitle: Intranasal administration of glial-derived neurotrophic factor (GDNF) rapidly and significantly increases whole-brain GDNF level in ratsJournal Name: NeurosciencePublisher: Elsevier BVVol: 303Issue #:Start Page: 569End Page: 576Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2015.07.016Citation Count: 44
- VPS13B is localized at the interface between Golgi cisternae and is a functional partner of FAM177A12024OPENTitle: VPS13B is localized at the interface between Golgi cisternae and is a functional partner of FAM177A1Journal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 223Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1083/jcb.202311189Best OA location URL: https://doi.org/10.1083/jcb.202311189Citation Count: 4
-
OPENTitle: Interview with Mark Frasier: A Michael J Fox Foundation Perspective on Precision Medicine in Parkinson’SJournal Name: Personalized MedicinePublisher: Informa UK LimitedVol: 14Issue #: 1Start Page: 13End Page: 15Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/pme-2016-0087Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/pme-2016-0087Citation Count: 0
-
OPENTitle: No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSFJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0130-3Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0130-3Citation Count: 21
-
OPENTitle: An ankyrin repeat chaperone targets toxic oligomers during amyloidogenesisJournal Name: Protein SciencePublisher: WileyVol: 32Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/pro.4728Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10367600Citation Count: 2
-
RESTRICTEDTitle: Evidence for topographic guidance of dopaminergic axons by differential Netrin-1 expression in the striatumJournal Name: Molecular and Cellular NeurosciencePublisher: Elsevier BVVol: 61Issue #:Start Page: 85End Page: 96Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.mcn.2014.05.003Citation Count: 34
-
RESTRICTEDTitle: 123I‐FP‐CIT SPECT [(123) I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α‐synuclein Parkinson's disease cohort versus Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 11Start Page: 1734End Page: 1739Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27451Citation Count: 12
- Determination of optimal vibration dose to treat Parkinson's disease gait symptoms: A clinical trial2024OPENTitle: Determination of optimal vibration dose to treat Parkinson's disease gait symptoms: A clinical trialJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 10Issue #:Start Page: 100248End Page: 100248Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100248Best OA location URL: https://doi.org/10.1016/j.prdoa.2024.100248Citation Count: 0
-
RESTRICTEDTitle: Conquering Neurologic Diseases in Primary CareJournal Name: Primary Care: Clinics in Office PracticePublisher: Elsevier BVVol: 51Issue #: 2Start Page: xvEnd Page: xviPublication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pop.2024.03.001Citation Count: 0
-
OPENTitle: RGS10 attenuates systemic immune dysregulation induced by chronic inflammatory stressJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-024-03322-1Best OA location URL: https://link.springer.com/content/pdf/10.1186/s12974-024-03322-1.pdfCitation Count: 0
-
RESTRICTEDTitle: Alterations in Blood Monocyte Functions in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 11Start Page: 1711End Page: 1721Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27815Citation Count: 81
-
OPENTitle: Transglutaminase 2 Depletion Attenuates α-Synuclein Mediated Toxicity in MiceJournal Name: NeurosciencePublisher: Elsevier BVVol: 441Issue #:Start Page: 58End Page: 64Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuroscience.2020.05.047Best OA location URL: https://doi.org/10.1016/j.neuroscience.2020.05.047Citation Count: 18
-
OPENTitle: New aspects of USP30 biology in the regulation of pexophagyJournal Name: AutophagyPublisher: Informa UK LimitedVol: 15Issue #: 9Start Page: 1634End Page: 1637Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/15548627.2019.1615304Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15548627.2019.1615304?needAccess=trueCitation Count: 14
-
OPENTitle: Activation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 MutationsJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 11Issue #: 11Start Page: e0166053End Page: e0166053Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0166053Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0166053&type=printableCitation Count: 18
-
OPENTitle: Grey matter abnormalities are associated only with severe cognitive decline in early stages of Parkinson's diseaseJournal Name: CortexPublisher: Elsevier BVVol: 123Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cortex.2019.09.015Best OA location URL: https://cris.maastrichtuniversity.nl/en/publications/226efa6a-7701-420c-935c-2c284c758e52Citation Count: 16
-
OPENTitle: Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer’s and Parkinson’s disease models of neurodegenerationJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddy308Citation Count: 30
-
OPENTitle: Voltage-Gated Proton Channel Hv1 Regulates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson’s Disease ModelsJournal Name: AntioxidantsPublisher: MDPI AGVol: 12Issue #: 3Start Page: 582End Page: 582Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/antiox12030582Best OA location URL: https://www.mdpi.com/2076-3921/12/3/582/pdf?version=1677573522Citation Count: 6
-
OPENTitle: Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson’s patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006)Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 57Issue #:Start Page: 102569End Page: 102569Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2021.102569Best OA location URL: https://doi.org/10.1016/j.scr.2021.102569Citation Count: 2
-
OPENTitle: Key Connectomes and Synaptic‐Compartment‐Specific Risk Genes Drive Pathological α‐Synuclein SpreadingJournal Name: Advanced SciencePublisher: WileyVol: 12Issue #: 25Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/advs.202413052Best OA location URL: https://advanced.onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202413052Citation Count: 1
-
OPENTitle: Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 10Start Page: 2329End Page: 2346Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.03.032Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.03.032Citation Count: 68
-
OPENTitle: Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohortJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 47Issue #:Start Page: 3End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.12.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5803409Citation Count: 47
- Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysis2018OPENTitle: Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 50Issue #:Start Page: 3End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.006Best OA location URL: http://www.prd-journal.com/article/S1353802018300427/pdfCitation Count: 69
-
OPENTitle: Distinct alterations in Parkinson's medication-state and disease-state connectivityJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 16Issue #:Start Page: 575End Page: 585Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2017.09.004Best OA location URL: https://doi.org/10.1016/j.nicl.2017.09.004Citation Count: 44
-
RESTRICTEDTitle: Comparing the Two Prodromal Parkinson's Disease Research Criteria—Lessons for Future StudiesJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1731End Page: 1732Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28637Citation Count: 8
-
OPENTitle: Bach1 derepression is neuroprotective in a mouse model of Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 118Issue #: 45Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2111643118Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8694049Citation Count: 63
-
OPENTitle: Clinical severity in Parkinson’s disease is determined by decline in cortical compensationJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 3Start Page: 871End Page: 886Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awad325Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad325/51777747/awad325.pdfCitation Count: 27
-
RESTRICTEDTitle: Single-cell multiomic analyses sheds light on mitochondrial mutational selectionJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 55Issue #: 7Start Page: 1083End Page: 1085Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41588-023-01436-5Best OA location URL: https://doi.org/10.1038/s41588-023-01436-5Citation Count: 1
-
OPENTitle: Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in proteinJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00322-xBest OA location URL: https://www.nature.com/articles/s41531-022-00322-x.pdfCitation Count: 9
-
RESTRICTEDTitle: Conjugal Synucleinopathies: A Clinicopathologic StudyJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 7Start Page: 1212End Page: 1217Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29783Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11260251Citation Count: 2
-
OPENTitle: Network Connectivity Alterations across the MAPT Mutation Clinical SpectrumJournal Name: Annals of NeurologyPublisher: WileyVol: 94Issue #: 4Start Page: 632End Page: 646Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ana.26738Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26738Citation Count: 4
-
OPENTitle: Increased substantia nigra echogenicity in LRRK2 family members without mutationsJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 9Start Page: 1504End Page: 1505Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27443Best OA location URL: https://europepmc.org/articles/pmc6346431?pdf=renderCitation Count: 2
-
OPENTitle: Alpha1-chimaerin, a Rac1 GTPase-activating protein, is expressed at reduced mRNA levels in the brain of Alzheimer’s disease patientsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 591Issue #:Start Page: 19End Page: 24Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2015.02.013Best OA location URL: http://doi.org/10.1016/j.neulet.2015.02.013Citation Count: 11
-
RESTRICTEDTitle: Incidence of Parkinson Disease in North America (P1-1.Virtual)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 18_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.98.18_supplement.2665Citation Count: 1
-
RESTRICTEDTitle: Utilising functional MRI (fMRI) to explore the freezing phenomenon in Parkinson’s diseaseJournal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 18Issue #: 6Start Page: 807End Page: 810Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2011.02.003Citation Count: 36
-
OPENTitle: In-depth mass-spectrometry reveals phospho-RAB12 as a blood biomarker of G2019S LRRK2-driven Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 148Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awae404Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awae404/61249433/awae404.pdfCitation Count: 0
-
OPENTitle: Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson’s disease and multiple system atrophyJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-019-0164-xBest OA location URL: https://translationalneurodegeneration.biomedcentral.com/track/pdf/10.1186/s40035-019-0164-xCitation Count: 145
-
OPENTitle: Good vibrations: tactile cueing for freezing of gait in Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 270Issue #: 7Start Page: 3424End Page: 3432Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-023-11663-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-023-11663-9.pdfCitation Count: 16
-
OPENTitle: Creating a patient‐centered guide to navigating cognitive change in Parkinson’s diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: S8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.041115Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.041115Citation Count: 0
-
RESTRICTEDTitle: Essential tremor plus is more common than essential tremor: Insights from the reclassification of a cohort of patients with lower limb tremorJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 56Issue #:Start Page: 109End Page: 110Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.06.029Citation Count: 69
-
OPENTitle: Daily-Living Freezing of Gait as Quantified Using Wearables in People With Parkinson Disease: Comparison With Self-Report and Provocation TestsJournal Name: Physical TherapyPublisher: Oxford University Press (OUP)Vol: 102Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/ptj/pzac129Best OA location URL: https://academic.oup.com/ptj/article-pdf/102/12/pzac129/48129224/pzac129.pdfCitation Count: 15
-
OPENTitle: Evaluation of alpha-synuclein immunohistochemical methods for the detection of Lewy-type synucleinopathy in gastrointestinal biopsiesJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-016-0305-8Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-016-0305-8Citation Count: 69
-
OPENTitle: Preliminary Assessment of Reference Region Quantification and Reduced Scanning Times for [18F]SynVesT-1 PET in Parkinson’s DiseaseJournal Name: Molecular ImagingPublisher: SAGE PublicationsVol: 2023Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2023/1855985Best OA location URL: https://downloads.hindawi.com/journals/moi/2023/1855985.pdfCitation Count: 13
-
OPENTitle: LRRK2-phosphorylated Rab10 sequesters Myosin Va with RILPL2 during ciliogenesis blockadeJournal Name: Life Science AlliancePublisher: Life Science Alliance, LLCVol: 4Issue #: 5Start Page: e202101050End Page: e202101050Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.26508/lsa.202101050Best OA location URL: https://www.life-science-alliance.org/content/lsa/4/5/e202101050.full.pdfCitation Count: 48
-
RESTRICTEDTitle: Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 82Issue #: 10_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.82.10_supplement.p1.016Citation Count: 0